The Reference-scaled Average Bioequivalence (RSABE) Approach
We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…
CertaraJuly 1, 2025
Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1
Radnor, PA – June 20, 2025 - Certara, Inc. (Nasdaq: CERT), a global leader in…
Danielle PillsburyJune 20, 2025
Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power
June 16, 2025 RADNOR, PA – June 16, 2025 – Certara, Inc. (Nasdaq: CERT), a…
CertaraJune 16, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer
The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…
CertaraJune 8, 2025
On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana
Phoenix NLME offers unparalleled flexibility and power for PK/PD analyses, meeting all scientific and technical…
Danielle PillsburyJune 5, 2025
Transform Your PK/PD Workflow with AI and the Cloud
Watch our on-demand webinar to see how AI and cloud technology will revolutionize your daily…
Danielle PillsburyJune 5, 2025
